Literature DB >> 1222762

Characterization of the immunostimulants levamisole and tetramisole.

F Spreafico, A Vecchi, A Mantovani, A Poggi, G Franchi, A Anaclerio, S Garattini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1222762     DOI： 10.1016/0014-2964(75)90127-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.

Authors:  J Zulman; J Michalski; C McCombs; J Greenspan; N Talal
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

3.  Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.

Authors:  R B Faanes; P Dillon; Y S Choi
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  The effect of E-N-L-trimethyllysine (TML) on the humoral and cellular immune response.

Authors:  G Elek; I Láng; B Szende; K Lapis
Journal:  Agents Actions       Date:  1982-10

5.  Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours.

Authors:  R Giavazzi; G Alessandri; F Spreafico; S Garattini; A Mantovani
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.